Sonic Healthcare Ltd
ASX:SHL

Watchlist Manager
Sonic Healthcare Ltd Logo
Sonic Healthcare Ltd
ASX:SHL
Watchlist
Price: 27.97 AUD 1.16% Market Closed
Market Cap: 13.4B AUD
Have any thoughts about
Sonic Healthcare Ltd?
Write Note

Net Margin
Sonic Healthcare Ltd

5.7%
Current
11%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.7%
=
Net Income
511.1m
/
Revenue
9B

Net Margin Across Competitors

Country AU
Market Cap 13.4B AUD
Net Margin
6%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country US
Market Cap 8.6B USD
Net Margin
13%
No Stocks Found

Sonic Healthcare Ltd
Glance View

Market Cap
13.4B AUD
Industry
Health Care

Sonic Healthcare Ltd. is a global leader in the provision of laboratory medicine and diagnostic services, successfully weaving its way into the fabric of healthcare across diverse markets. Founded in Australia in 1987, the company has expanded its operations internationally, boasting a network that spans Europe, North America, Asia, and New Zealand. Sonic's core business involves pathology and radiology services, which cater to hospitals, general practices, and patients, ensuring accurate and timely diagnoses. With a keen focus on innovation, Sonic integrates advanced technology and artificial intelligence into its processes, enhancing the quality and efficiency of its services, while also adhering to stringent regulatory standards. This commitment to excellence has positioned Sonic as a trusted partner in the healthcare ecosystem, crucial for both patient outcomes and the smooth functioning of healthcare systems. Investors looking at Sonic Healthcare will appreciate the company's resilient growth trajectory and prudent operational strategy. The company's revenue stream is underpinned by long-term contracts with healthcare providers and government entities, providing a stable and predictable cash flow. Sonic has demonstrated a history of profitability, underpinned by strategic acquisitions that bolster its market share and capabilities. Furthermore, the company's significant investment in research and development not only drives technological advancements but also aligns with evolving healthcare needs. As the global demand for diagnostic services continues to rise, driven by factors like an aging population and increased emphasis on preventive care, Sonic Healthcare presents a compelling investment opportunity for those seeking exposure to the robust and essential healthcare sector.

SHL Intrinsic Value
31.37 AUD
Undervaluation 11%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.7%
=
Net Income
511.1m
/
Revenue
9B
What is the Net Margin of Sonic Healthcare Ltd?

Based on Sonic Healthcare Ltd's most recent financial statements, the company has Net Margin of 5.7%.